Overall survival rates of 200 patients with non-Hodgkin lymphoma by the pretreatment S-VEGF and S-bFGF.

The highest quartiles (S-VEGF, 462 pg/mL or more; S-bFGF, 5.5 pg/mL or more) were used as the cutoff values. Survival rates at 24 and 60 months are given. The plotted cumulative survival lines are shown for the patients with both S-VEGF and S-bFGF within the highest quartiles, for the patients with both S-VEGF and S-bFGF within the 3 lowest quartiles, and for the patients who had one of the factors within the highest quartile and the other factor within the 3 lowest quartiles (the line in the middle).